Hemangioma is one of the most common congenital tumors in the region of the face and neck. Although histologically benign, these facial masses are clinically malignant for their deforming and inexorable growth, especially in so-called cavernous hemangioma. Today, hemagiomas have been treated by various methods; steroids, electrocoagulation, injection of sclerosing agent, cryotherapy, radiation therapy, laser therapy, and surgical treatment, etc. The response of treatment varies with the types, surgical skills, regions of hemangioma, the age of patient, but the appropriate method of the treatment has not been yet established. In the case of massive hemangioma, which involves most part of the face and neck, we prefer surgical treatment and consistently obtain better result than other treatment modalities. Wide excision and proper reconstruction of the face helps the patient for their better life aesthetically and functionally.
Cryotherapy ; Electrocoagulation ; Hemangioma* ; Hemangioma, Cavernous ; Humans ; Laser Therapy ; Neck* ; Steroids

Female ; Hemangioma ; therapy ; Humans ; Infant, Newborn ; Syndrome ; Thrombocytopenia ; therapy

Hemangioma is benign tumor that represent an fail in development of the vascular system, network or retiform stage. As with hemangioma elsewhere, spontaneous regression may occur. Histologically capillary hemangioma has a diagnostic lobular arrangement of capillaries and almost all of them are located in nasal or oral mucous membranes. But, as we know, there is no report of hemangioma located in the trachea in Korea, so we report a case of tracheal hemangioma which was manifested massive hemoptysis.
Capillaries ; Hemangioma* ; Hemangioma, Capillary ; Hemoptysis* ; Korea ; Laser Therapy ; Mucous Membrane ; Trachea

Face ; blood supply ; Hemangioma ; therapy ; Humans ; Vascular Malformations ; therapy ; Vasculitis ; therapy

Antineoplastic Agents ; therapeutic use ; Cryotherapy ; Head and Neck Neoplasms ; therapy ; Hemangioma ; therapy ; Humans ; Laser Therapy

Acupuncture Therapy ; Adult ; Female ; Hemangioma, Cavernous ; physiopathology ; therapy ; Humans ; Lingual Frenum ; physiopathology ; Tongue Diseases ; physiopathology ; therapy

Hemangioma is one of the most common congenital tumors in the region of the face and neck. Although histologically benign, these facial masses are clinically malignant for their deforming and inexorable growth, especially in so-called 'cavernous hemangioma'. Carvenous hemangioma is the most common primary tumor occurring in the adult orbit. This tumor has symptoms that characteristically develop over several years with slowly progressive proptosis, eyeball deviation, hyperopia, diplopia and optic nerve compression. Today, hemangiomas are being treated by various methods; steroids, electrocoagulation, injection of sclerosing agent, cryotherapy, radiation therapy, laser therapy, and surgical treatment, etc. In principle, surgical approaches to the orbit must provide maximum safety and optimal visualization. We have experienced a case of large cavernous hemangioma in the orbit inferolaterally. The surgical treatment of tumor was achieved by the bicoronal approach combined with inferomedial and inferolateral orbitotomy. This surgical approach allows better visualization of the tumor and greater protection of essential anatomic structures. We obtained satisfactory results in terms of aesthetic and functional consideration. We present our case with a brief review of the literature related to orbital cavernous hemangioma.
Adult ; Cryotherapy ; Diplopia ; Electrocoagulation ; Exophthalmos ; Hemangioma ; Hemangioma, Cavernous* ; Humans ; Hyperopia ; Laser Therapy ; Neck ; Optic Nerve ; Orbit* ; Steroids

BACKGROUND: 585nm flashlamp-pumped pulsed dye laser(FPDL) is a very effective treatment modality for vascular skin lesions with minimal risk of scarring by selective photothermolysis. OBJECTIVE: The purpose of this study was to evaluate the effectiveness of FPDL in treating various vascular lesions in Korean patients, and in order to be helpful in expecting the treatment outcome and selecting the patients. METHODS: 216 cases treated with FPDL because of vasular skin lesions- nevus flammeus, telangiectasia, hemangioma and others- were included in this study. The results of the treatment were evaluated in the point of site, color, size, surface contour of lesions and patient's age in each condition. Photographs were obtained at baseline and 4~8 week intervals postoperatively. The results were assessed by two blinded assessors and surgeon after laser surgery, based on a scale of: poor for 0~25% improvement; fair for 25~50% improvement; good for 50~75% improvement; and excellent for 75~100% improvement. RESULTS: The commonest disease for treatment was nevus flammeus, followed by telangiectasia and strawberry hemangioma. In nevus flammeus, the lesions at upper eyelids, lower eyelids, upper lip skin and lesions which were darker in color and more elevated, responded less favorably. Age and sex of patients didn't affect the outcome. In telangiectasia, the results of treatment were above good in 83% of cases. In strawberry hemangioma, the results of treatment were above good in 73% of cases. CONCLUSION: FPDL is very effective in various vascular lesions, but one must keep in mind the differences in treatment outcome according to sites, color, size, surface contour of lesions.
Cicatrix ; Eyelids ; Hemangioma ; Hemangioma, Cavernous ; Humans ; Laser Therapy ; Lasers, Dye* ; Lip ; Port-Wine Stain ; Skin* ; Telangiectasis ; Treatment Outcome

hemangioma. The decision to initiate treatment is based on many factors, including size, location and risks and benefits of the proposal therapy. Systemic corticosteroids are decided to prevent the scarring and deforming. Prednisolone was given at a dose of 2 mg/kg/day for 2 weeks followed by tapering for 6 weeks for treatment. After eight weeks there was 80% reduction in the size of the lesion and the left lower lip almost completely cleared without intraoral bleeding. Furthermore, intervention by way of systemic steroids, laser therapy or surgical debulking is appropriate and safe in a select group of patients presenting with a proliferating hemangioma. This report describes a case that was sucessfully treated by systemic steroid therapy for hemangima in intraoral region.]]>
Adrenal Cortex Hormones ; Cicatrix ; Hemangioma ; Hemangioma, Capillary ; Hemorrhage ; Humans ; Infant ; Laser Therapy ; Lip ; Male ; Parturition ; Prednisolone ; Risk Assessment ; Steroids

OBJECTIVETo explore the clinical effect and appropriate power of high-intensity focused ultrasound (HIFU) in the treatment of infant hemangioma.

METHODS80 infants with hemangioma were randomly divided into four groups, 20 cases in each group. All cases in group A, B and C were irradiated on the lesion surface with 3-5 mm/s speed for five continuous come-and-goes using HIFU, with frequency 9 MHz, impulse 1 000 Hz and 10% scanning overlap. The power was respectively 3.5 W in group A, 4.0 W in group B and 4.5 W in group C. One session contained three times of treatment, with one month interval. The cases in group D were only followed up as control group. The therapeutic effect, ulcer and scar in irradiated region in group A, B, C were observed 6 months after the last treatment, which were synchronously compared with those in group D.

RESULTS6 months after the last treatment, 7, 9, 8 cases were cured and 9, 8, 10 cases were almost cured, and 4, 3, 2 cases got improved in group A, B, C, respectively. The total effective rate was 100% in the three groups. While only 5 cases got improved in group D. The treatment effect in group A, B and C was obviously better than that in group D (P < 0.05), with no significant difference among the three groups statistically (P > 0.05). Ulcer and scar in irradiated skin occurred in 0,4,6,0 cases in group A, B, C and D, respectively. The incidence of ulcer and scar was obviously higher in group B and C than that in group A and D statistically (P < 0.05).

CONCLUSIONSHIFU irradiating is one of effective methods for infant hemangioma treatment. The appropriate power should not be above 3.5 W.